A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer

Condition:   Epithelial Ovarian Cancer Intervention:   Drug: Envafolimab Sponsor:   Hebei Medical University Fourth Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials